Luncheon Symposia Series

Complimentary lunch provided by ARRS for up to 200

Monday, May 6, 11:30 am–12:30 pm

Location: Room 313


Mitigation of Risk in Radiology

SPONSORED BY BRACCO DIAGNOSTICS, INC

FACULTY:
Nicolas Argy, MD, JD
Nicolas Argy, MD, JD Consultants
Boston, MA

MODERATOR:
Suresh K. Mukherji, MD
Michigan State University
East Lansing, MI

Risk management in radiology is essential in protecting the entire continuum of care—from patients and radiologists to the entire medical organization. Learn about the reduction of risk in the MR suite in the era of gadolinium retention from a leading expert in public health, risk management, process improvement, patient safety, and medical errors.

For information regarding registering, contact BraccoARRS@diag.bracco.com.

This Symposium does not offer CME.

Tuesday, May 7, 11:30 am–12:30 pm

Location: Room 313


What You Need to Know: The Impacts of Stability of GBCAs 

SPONSORED BY GUERBET, LLC

FACULTY:
Lawrence N. Tanenbaum, MD 
RadNet 
New York, NY

This presentation will highlight the importance of gadolinium and the rationales behind chelation and how structure and ionicity affect GBCA stability. Discussions around the performance of different chelates and how they relate to kinetic and thermodynamic stability and a review of the regulatory status regarding macrocyclics versus linear agents will be outlined. 

This Symposium does not offer CME. 
 

Wednesday, May 8, 11:30 am–12:30 pm

Location: Room 313


Tomosynthesis...The New Mammogram

SPONSORED BY AN UNRESTRICTED EDUCATIONAL GRANT FROM HOLOGIC, INC

FACULTY: 
Tanya W. Moseley, MD 
Professor of Diagnostic Radiology
MD Anderson Cancer Center
Houston, TX

Studies have shown that tomosynthesis increases cancer detection rate and decreases false positive. Why then haven't all breast centers converted to tomosynthesis? Is tomosynthesis the new mammogram?

Up to 1 AMA PRA Category 1 Credit available through Ciné-Med

In support of improving patient care, Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Ciné-Med designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Information for claiming CME Credit will be provided at the Luncheon Symposia

To pre-register for the session, visit: https://cine-med.com/tomo/

The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 1 AMA/PRA Category 1 CME Credit.™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Thursday, May 9, 11:30 am–12:30 pm

Location: Room 313


An Interactive, Case-Based Discussion: Improving Outcomes in Progressive Fibrosing - Interstitial Lung Disease (PF-ILD) through Early and Accurate Diagnosis

THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

FACULTY: 
Joshua J. Solomon, MD
Associate Chief, Section of Critical Care
Associate Professor
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, CO

Michael Kadoch, MD
Assistant Professor
Chief, Cardiothoracic Radiology
University of California, Davis
Sacramento, CA

Justin M. Oldham, MD, MS
Assistant Professor of Medicine
Director, Interstitial Lung Disease Program
University of California, Davis
Sacramento, CA

Progressive fibrosing-interstitial lung disease (PF-ILD) is a serious pulmonary disorder that can impact affected patients with significant morbidity and mortality. Diagnosis of PF-ILD is generally complicated because there are more than 100 forms of ILD described. Clinicians must be able to delineate the pathophysiologic mechanisms behind the various forms of PF-ILD, and identify associated pathological fibrosis patterns to promote earlier diagnosis for prompt intervention. Active collaboration with patients to address therapeutic options for these disorders includes potential enrollment in clinical trials for emerging therapies. With an ever-changing landscape for management of PF-ILDs, it is critical that clinicians be educated on all aspects of these disorders, including new pathways to improving patient management and optimizing overall outcomes. This interactive symposium is specifically designed to inform radiologists on early recognition, differential and accurate diagnosis, as well as the new and emerging treatments for patients with PF-ILDs.

To pre-register for the session, visit: https://www.gotoper.com/conferences/arrs19iss/meetings/arrs-iss19 or call Physicians’ Education Resource at (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This activity is held in conjunction with the ARRS 2019 Annual Meeting but is not part of the ARRS CME program. CME credit must be claimed separately through the accrediting provider. Attendance is open to ARRS Annual Meeting and Virtual Meeting registrants only.